R H White

Summary

Affiliation: University of California
Country: USA

Publications

  1. ncbi request reprint Reversal of elevated international normalized ratios and bleeding with low-dose recombinant activated factor VII in patients receiving warfarin
    William E Dager
    Department of Pharmaceutical Services, University of California, Davis Medical Center, Sacramento, California 95817 2201, USA
    Pharmacotherapy 26:1091-8. 2006
  2. ncbi request reprint Anticoagulation therapy after recent bleeding: is it ever safe?
    R H White
    Division of General Medicine, Anticoagulation Service, Sacramento, CA 95817, USA
    J Thromb Haemost 4:2365-6. 2006
  3. doi request reprint High variation between hospitals in vena cava filter use for venous thromboembolism
    Richard H White
    Division ofGeneral Medicine, Departmentsof Medicine, University of California, Davis, School of Medicine, Sacramento, CA 95817, USA
    JAMA Intern Med 173:506-12. 2013
  4. doi request reprint Evaluation of the predictive value of ICD-9-CM coded administrative data for venous thromboembolism in the United States
    Richard H White
    Division of General Medicine, University of California, Davis, CA, USA
    Thromb Res 126:61-7. 2010
  5. ncbi request reprint Low-molecular-weight heparins: are they all the same?
    Richard H White
    Division of General Medicine, University of California Davis, 4150 V Street, Sacramento, CA 95817, USA
    Br J Haematol 121:12-20. 2003
  6. ncbi request reprint Targeting patients for anticoagulant prophylaxis trials in patients with cancer: who is at highest risk?
    Richard H White
    Department of Internal Medicine, University of California, Davis Sacramento, CA, USA
    Thromb Res 120:S29-40. 2007
  7. ncbi request reprint The epidemiology of venous thromboembolism
    Richard H White
    University of California, Davis, Sacramento, California, USA
    Circulation 107:I4-8. 2003
  8. ncbi request reprint Incidence of symptomatic venous thromboembolism after different elective or urgent surgical procedures
    Richard H White
    Division of General Medicine, University of California, Davis, California, USA
    Thromb Haemost 90:446-55. 2003
  9. ncbi request reprint Racial and gender differences in the incidence of recurrent venous thromboembolism
    Richard H White
    Department of Medicine, UC Davis, Davis, California, USA
    Thromb Haemost 96:267-73. 2006
  10. ncbi request reprint Effect of age on the incidence of venous thromboembolism after major surgery
    R H White
    Division of General Medicine, University of California, Davis, USA
    J Thromb Haemost 2:1327-33. 2004

Detail Information

Publications69

  1. ncbi request reprint Reversal of elevated international normalized ratios and bleeding with low-dose recombinant activated factor VII in patients receiving warfarin
    William E Dager
    Department of Pharmaceutical Services, University of California, Davis Medical Center, Sacramento, California 95817 2201, USA
    Pharmacotherapy 26:1091-8. 2006
    ..To assess the effectiveness of using low-dose recombinant activated factor VII (rFVIIa) to reverse the effects of warfarin in critically ill patients with major bleeding events...
  2. ncbi request reprint Anticoagulation therapy after recent bleeding: is it ever safe?
    R H White
    Division of General Medicine, Anticoagulation Service, Sacramento, CA 95817, USA
    J Thromb Haemost 4:2365-6. 2006
  3. doi request reprint High variation between hospitals in vena cava filter use for venous thromboembolism
    Richard H White
    Division ofGeneral Medicine, Departmentsof Medicine, University of California, Davis, School of Medicine, Sacramento, CA 95817, USA
    JAMA Intern Med 173:506-12. 2013
    ..The extent to which vena cava filter (VCF) use varies between hospitals in the management of acute venous thromboembolism (VTE) is not clear...
  4. doi request reprint Evaluation of the predictive value of ICD-9-CM coded administrative data for venous thromboembolism in the United States
    Richard H White
    Division of General Medicine, University of California, Davis, CA, USA
    Thromb Res 126:61-7. 2010
    ..To determine the positive predictive value of International Classification of Disease, 9th Revision, Clinical Modification (ICD-9-CM) discharge codes for acute deep vein thrombosis or pulmonary embolism...
  5. ncbi request reprint Low-molecular-weight heparins: are they all the same?
    Richard H White
    Division of General Medicine, University of California Davis, 4150 V Street, Sacramento, CA 95817, USA
    Br J Haematol 121:12-20. 2003
  6. ncbi request reprint Targeting patients for anticoagulant prophylaxis trials in patients with cancer: who is at highest risk?
    Richard H White
    Department of Internal Medicine, University of California, Davis Sacramento, CA, USA
    Thromb Res 120:S29-40. 2007
    ..It is not clear which cancer patients are at highest risk for developing venous thromboembolism (VTE)...
  7. ncbi request reprint The epidemiology of venous thromboembolism
    Richard H White
    University of California, Davis, Sacramento, California, USA
    Circulation 107:I4-8. 2003
    ..Early mortality after VTE is strongly associated with presentation as PE, advanced age, cancer, and underlying cardiovascular disease...
  8. ncbi request reprint Incidence of symptomatic venous thromboembolism after different elective or urgent surgical procedures
    Richard H White
    Division of General Medicine, University of California, Davis, California, USA
    Thromb Haemost 90:446-55. 2003
    ..Because of the high incidence of VTE diagnosed after hospital discharge, further studies of extended thromboprophylaxis appear warranted...
  9. ncbi request reprint Racial and gender differences in the incidence of recurrent venous thromboembolism
    Richard H White
    Department of Medicine, UC Davis, Davis, California, USA
    Thromb Haemost 96:267-73. 2006
    ..The effect of gender on the risk of recurrent venous thromboembolism can not be generalized because it varies between racial/ethnic groups and with the type of index event...
  10. ncbi request reprint Effect of age on the incidence of venous thromboembolism after major surgery
    R H White
    Division of General Medicine, University of California, Davis, USA
    J Thromb Haemost 2:1327-33. 2004
    ..We sought to quantify the effect of age on the risk of symptomatic VTE after a spectrum of surgical procedures...
  11. ncbi request reprint Incidence of venous thromboembolism in the year before the diagnosis of cancer in 528,693 adults
    Richard H White
    Departments of Internal Medicine, Medicine, Medicine and Statistics, and Public Health Sciences, University of California Davis, Sacramento, CA 95817, USA
    Arch Intern Med 165:1782-7. 2005
    ..It is unclear how frequently unprovoked venous thromboembolism (VTE) reflects the presence of an occult cancer...
  12. ncbi request reprint ICD-9-CM codes poorly indentified venous thromboembolism during pregnancy
    Richard H White
    Division of General Medicine, University of California Davis, Suite 2400, 4150 V Street, Sacramento, CA 95817, USA
    J Clin Epidemiol 57:985-8. 2004
    ..There is little data regarding the accuracy of pregnancy-specific ICD-9-CM codes used to identify patients with venous thromboembolism (VTE)...
  13. doi request reprint Death due to recurrent thromboembolism among younger healthier individuals hospitalized for idiopathic pulmonary embolism
    Richard H White
    Division of General Medicine, University of California, Davis, California, USA
    Thromb Haemost 99:683-90. 2008
    ..Among the patients who died of thromboembolism >28 days after the index PE, 28% had developed pulmonary hypertension...
  14. ncbi request reprint Recurrent venous thromboembolism after pregnancy-associated versus unprovoked thromboembolism
    Richard H White
    Department of Internal Medicine, UC Davis, Sacramento, CA 95817, USA
    Thromb Haemost 100:246-52. 2008
    ..These findings should be considered when decisions are made about VTE prophylaxis in women with a history of pregnancy-associated VTE...
  15. ncbi request reprint Effect of weight, sex, age, clinical diagnosis, and thromboplastin reagent on steady-state intravenous heparin requirements
    R H White
    Division of General Medicine, University of California, Davis, USA
    Arch Intern Med 157:2468-72. 1997
    ..Less is known about whether sex, age, clinical diagnosis, and the thromboplastin used to measure the activated partial thromboplastin time (aPTT) affect heparin dose requirements...
  16. ncbi request reprint Length of hospital stay for treatment of deep venous thrombosis and the incidence of recurrent thromboembolism
    R H White
    Division of General Medicine, University of California at Davis, Sacramento 95817, USA
    Arch Intern Med 158:1005-10. 1998
    ..Current guidelines suggest that all patients with acute deep venous thrombosis should be treated with intravenous heparin for at least 5 days, overlapping with warfarin sodium for 4 to 5 days...
  17. doi request reprint Recurrent venous thromboembolism after surgery-provoked versus unprovoked thromboembolism
    R H White
    Department of Medicine, UC Davis School of Medicine, Sacramento, CA, USA
    J Thromb Haemost 8:987-97. 2010
    ..The incidence of recurrent venous thromboembolism (VTE) varies depending on the nature of the initial provoking risk factor(s)...
  18. ncbi request reprint A population-based study of the effectiveness of inferior vena cava filter use among patients with venous thromboembolism
    R H White
    Division of General Medicine, Suite 2400, PSSB, 4150 V St, Sacramento, CA 95817, USA
    Arch Intern Med 160:2033-41. 2000
    ..There are few population-based data regarding the effectiveness of inferior vena cava filter use in the prevention of symptomatic pulmonary embolism...
  19. ncbi request reprint Temporary reversal of anticoagulation using oral vitamin K
    R H White
    University of California, Davis, Sacramento, California, USA
    J Thromb Thrombolysis 10:149-53. 2000
    ..5 (r=-0.52, p=0.011). Use of a 2.0 mg oral dose of vitamin K(1) does not reliably reverse (correct) a therapeutic INR in patients maintained on their daily dose of warfarin...
  20. ncbi request reprint Predictors of rehospitalization for symptomatic venous thromboembolism after total hip arthroplasty
    R H White
    Department of Medicine, University of California, Davis, Sacramento, USA
    N Engl J Med 343:1758-64. 2000
    ..Risk factors associated with these symptomatic thromboembolic events are not well defined...
  21. doi request reprint How valid is the ICD-9-CM based AHRQ patient safety indicator for postoperative venous thromboembolism?
    Richard H White
    Division of General Medicine, University of California, Davis, CA 95817, USA
    Med Care 47:1237-43. 2009
    ..However, few studies have evaluated the accuracy of these ICD-9-CM codes across multiple hospitals...
  22. doi request reprint Effects of race and ethnicity on the incidence of venous thromboembolism
    Richard H White
    University of California, Davis, Sacramento, USA
    Thromb Res 123:S11-7. 2009
    ..Race/ethnicity should be considered an important factor in the risk-stratification of patients with suspected VTE or patients at some risk for developing VTE...
  23. doi request reprint Long-term incidence of death due to thromboembolic disease among patients with unprovoked pulmonary embolism
    Richard H White
    Division of General Internal Medicine, University of California, Davis, Sacramento, California 95817, USA
    Curr Opin Pulm Med 15:418-24. 2009
    ..These findings will aid clinicians who must weigh the risk versus the benefits of long-term anticoagulant therapy...
  24. ncbi request reprint Effect of ethnicity and gender on the incidence of venous thromboembolism in a diverse population in California in 1996
    Richard H White
    Division of General Medicine, University of California, Davis, California, USA
    Thromb Haemost 93:298-305. 2005
    ..Further research is needed to explain these observed differences among the different racial/ethnic groups...
  25. doi request reprint The incidence of venous thromboembolism among patients with primary lung cancer
    H K Chew
    Division of Hematology Oncology, Department of Internal Medicine, University of California Davis, Sacramento, CA, USA
    J Thromb Haemost 6:601-8. 2008
    ..Objectives: To determine the incidence of VTE and the risk factors associated with development of VTE in a large population-based study of patients with non-small cell and small cell lung cancer...
  26. ncbi request reprint The incidence and case-fatality rates of acute biliary, alcoholic, and idiopathic pancreatitis in California, 1994-2001
    Charles F Frey
    Department of Surgery, UC Davis Medical Center, Sacramento, CA, USA
    Pancreas 33:336-44. 2006
    ..To better define the epidemiology of acute pancreatitis in a racially diverse population...
  27. ncbi request reprint Venous thromboembolism in patients with colorectal cancer: incidence and effect on survival
    Allison Alcalay
    Division of Hematology and Oncology, Department of Internal Medicine, University of California, Davis, Sacramento, CA 95817, USA
    J Clin Oncol 24:1112-8. 2006
    ..To describe the incidence and outcomes associated with venous thromboembolism (VTE) among patients with colorectal cancer...
  28. doi request reprint Risk of cancer among rheumatoid arthritis patients in California
    Arti Parikh-Patel
    California Cancer Registry, Public Health Institute, 1825 Bell Street, Suite 102, Sacramento, CA 95825, USA
    Cancer Causes Control 20:1001-10. 2009
    ..The objective of this retrospective cohort study was to evaluate cancer risk among rheumatoid arthritis (RA) patients in California...
  29. ncbi request reprint Anticoagulation in the elderly
    M C Henderson
    Department of Internal Medicine, University of California Davis, 4150 V Street, Sacramento, CA 95817, USA
    Curr Opin Pulm Med 7:365-70. 2001
    ..This information should enable practitioners to better assess the relative risks and benefit of oral anticoagulation therapy to guide treatment decisions in the elderly...
  30. ncbi request reprint Optimization of inpatient warfarin therapy: impact of daily consultation by a pharmacist-managed anticoagulation service
    W E Dager
    Department of Pharmaceutical Services, University of California, Davis Medical Center, Sacramento 95817, USA
    Ann Pharmacother 34:567-72. 2000
    ..To determine the effect of daily consultation by a team of hospital pharmacists on the accuracy and rapidity of optimizing warfarin therapy...
  31. ncbi request reprint Deep vein thrombosis and pulmonary embolism in two cohorts: the longitudinal investigation of thromboembolism etiology
    Mary Cushman
    Department of Medicine, University of Vermont, Burlington, USA
    Am J Med 117:19-25. 2004
    ..To determine the incidence of deep vein thrombosis and pulmonary embolism in two cohorts representing regions of the United States...
  32. ncbi request reprint Venous thromboembolism after spinal cord injury: incidence, time course, and associated risk factors in 16,240 adults and children
    Tracey Jones
    Department of Physical Medicine and Rehabilitation, Center for Health Services Research in Primary Care, University of California, Davis, CA, USA
    Arch Phys Med Rehabil 86:2240-7. 2005
    ..To analyze the incidence of venous thromboembolism (VTE) after spinal cord injury (SCI)...
  33. doi request reprint Risk of stroke after surgery in patients with and without chronic atrial fibrillation
    S Kaatz
    Department of Medicine, Henry Ford Hospital, Detroit, MI 48202, USA
    J Thromb Haemost 8:884-90. 2010
    ..The extent to which chronic atrial fibrillation affects the risk of postoperative stroke is largely unknown...
  34. ncbi request reprint Early morbidity after total hip replacement: rheumatoid arthritis versus osteoarthritis
    R H White
    Department of Internal Medicine, University of California, Davis
    J Gen Intern Med 5:304-9. 1990
    ..The short-term outcome of patients with rheumatoid arthritis appears comparable to that of patients with osteoarthritis...
  35. ncbi request reprint Treatment of heparin-induced thrombocytopenia
    William E Dager
    Department of Pharmaceutical Services, The University of California, Davis Medical Center, Sacramento 95817, USA
    Ann Pharmacother 36:489-503. 2002
    ..To describe heparin-induced thrombocytopenia (HIT or HIT-2), an immune-mediated adverse reaction to heparin or low-molecular-weight heparin. Available treatment options and considerations in developing a therapy approach are discussed...
  36. doi request reprint Cancer risk in a cohort of patients with systemic lupus erythematosus (SLE) in California
    Arti Parikh-Patel
    California Cancer Registry, Public Health Institute, 1700 Tribute Road, Suite100, Sacramento, CA 95815 4402, USA
    Cancer Causes Control 19:887-94. 2008
    ..We conducted a retrospective cohort study to examine cancer risk in a large cohort of systemic lupus erythematosus (SLE) patients in California...
  37. doi request reprint Venous thromboembolism (VTE) in patients with cancer: epidemiology and risk factors
    Ted Wun
    Division of Hematology and Oncology, Department of Internal Medicine, University of California, Davis, California 95187, USA
    Cancer Invest 27:63-74. 2009
    ..Development of VTE is clearly associated with decreased survival and this effect is greater among patients initially diagnosed with local or regional stage cancer compared to patients with metastatic cancer...
  38. doi request reprint Venous thromboembolism in patients with acute leukemia, lymphoma, and multiple myeloma
    Ted Wun
    Division of Hematology and Oncology, UC Davis School of Medicine, Sacramento, CA 95670, USA
    Thromb Res 125:S96-102. 2010
    ..Primary and secondary pharmacological prophylaxis can be problematic in these patients who are often thrombocytopenic. Strategies to prevent VTE, especially upper extremity catheter-associated thrombosis need to be developed...
  39. pmc N-of-1 trials of expensive biological therapies: a third way?
    Richard L Kravitz
    Division of General Medicine and Center for Healthcare Policy and Research, University of California, Davis, School of Medicine, Sacramento, CA 95817, USA
    Arch Intern Med 168:1030-3. 2008
    ..In the primary model, the n-of-1 trial option was 15% more expensive than stepped care but 47% cheaper than open access to etanercept. More research is needed on the acceptability, safety, and generalizability of this promising approach...
  40. ncbi request reprint Pharmacotherapy of heparin- induced thrombocytopenia
    William E Dager
    Anticoagulation Service, UC Davis Medical Center, UC Davis School of Medicine, Sacramento CA, USA
    Expert Opin Pharmacother 4:919-40. 2003
    ....
  41. ncbi request reprint The effects of race/ethnicity and sex on the risk of venous thromboembolism
    Craig R Keenan
    Division of General Internal Medicine, University of California, Davis, Sacramento, California 95817, USA
    Curr Opin Pulm Med 13:377-83. 2007
    ..We review the influence of race/ethnicity and sex on venous thromboembolism, concentrating on articles from 2005 to 2007...
  42. ncbi request reprint An economic model of adverse events and costs for oral anticoagulants used for atrial fibrillation
    J Paul Leigh
    Center for Healthcare Policy and Research and Department of Public Health Sciences, University of California, Davis, CA 95616 5270, USA
    Curr Med Res Opin 23:2071-81. 2007
    ..To construct a semi-Markov model to compare health outcomes and medical costs associated with warfarin and a second anticoagulant over 1- and 5-year periods...
  43. ncbi request reprint Risk factors for venous thromboembolism after total hip and knee replacement surgery
    Richard H White
    Division of General Medicine, University of California, Sacramento, California 95817, USA
    Curr Opin Pulm Med 8:365-71. 2002
    ..Factors associated with lower risk include (1) Asian/Pacific Islander ethnicity, (2) use of pneumatic compression among non-obese patients after surgery, and (3) extended thromboprophylaxis after hospital discharge...
  44. ncbi request reprint Venous thromboembolism in ovarian cancer
    Anne O Rodriguez
    Department of Obstetrics and Gynecology, University of California Davis, USA
    Gynecol Oncol 105:784-90. 2007
    ..To determine the incidence, time-course, and risk factors associated with the development of thromboembolism (VTE) in a population-based study of women with ovarian cancer...
  45. ncbi request reprint Incidence of venous thromboembolism and its effect on survival among patients with common cancers
    Helen K Chew
    Divisionsof Hematology Oncology, Department of Internal Medicine, and Department of Public Health Sciences, University of California, Davis, Sacramento, CA 95817, USA
    Arch Intern Med 166:458-64. 2006
    ..The incidence of venous thromboembolism after diagnosis of specific cancers and the effect of thromboembolism on survival are not well defined...
  46. ncbi request reprint Age as a risk factor for venous thromboembolism after major surgery
    Craig R Keenan
    Department of Medicine, Division of General Medicine, University of California, Davis, California 95817, USA
    Curr Opin Pulm Med 11:398-402. 2005
    ..This article reviews the recent literature on the effect of age on the incidence of postoperative venous thromboembolism...
  47. ncbi request reprint Mandating coverage of biologic therapies for rheumatic disease: where evidence and politics meet
    Yali A Bair
    Center for Health Services Research in Primary Care, University of California Davis, 2103 Stockton Boulevard, Sacramento, CA 95817, USA
    Arthritis Rheum 55:353-4. 2006
    ..We hope that the readership of Arthritis Care & Research find this article informative as an exemplar of the policies that could dramatically alter the welfare of our patients...
  48. ncbi request reprint Patient self-management of oral anticoagulation
    Tonya L Fancher
    Division of General Medicine, University of California, Davis Patient Support Services Building, Suite 2400, Sacramento, CA 95817, USA
    Curr Hematol Rep 3:368-74. 2004
    ..This article reviews the evidence behind the efficacy, safety, and cost effectiveness of PSM...
  49. ncbi request reprint Low-molecular-weight heparin-induced thrombocytopenia in a child
    William E Dager
    Department of Pharmaceutical Services, University of California, Davis Medical Center, Sacramento, CA 95817 2201, USA
    Ann Pharmacother 38:247-50. 2004
    ..To report a case of probable acute venous thrombosis caused by heparin-induced thrombocytopenia (HIT) in a pediatric patient with a normal platelet count after prolonged enoxaparin therapy...
  50. ncbi request reprint Argatroban for heparin-induced thrombocytopenia in hepato-renal failure and CVVHD
    William E Dager
    Department of Pharmaceutical Services, University of California Davis Medical Center, Sacramento, CA 95817 2201, USA
    Ann Pharmacother 37:1232-6. 2003
    ..To report a case of significant hepatic and renal failure with the use of argatroban in a patient with heparin-induced thrombocytopenia (HIT) requiring continuous veno-veno hemodialysis (CVVHD)...
  51. ncbi request reprint Incidence of venous thromboembolism and the impact on survival in breast cancer patients
    Helen K Chew
    Division of Hematology Oncology, University of California Davis, CA, USA
    J Clin Oncol 25:70-6. 2007
    ..The incidence of venous thromboembolism (VTE) and the risk factors associated with development of VTE have not been reported in a large population-based study of breast cancer patients...
  52. pmc Combined use of rapid D-dimer testing and estimation of clinical probability in the diagnosis of deep vein thrombosis: systematic review
    Tonya L Fancher
    Division of General Medicine, University of California at Davis, Patient Support Services Building, Suite 2400, Sacramento, California 95817, USA
    BMJ 329:821. 2004
    ..To summarise the evidence supporting the use of rapid d-dimer testing combined with estimation of clinical probability to exclude the diagnosis of deep venous thrombosis among outpatients...
  53. ncbi request reprint Tinzaparin in outpatients with pulmonary embolism or deep vein thrombosis
    William E Dager
    Department of Pharmaceutical Services, University of California Davis Medical Center, Sacramento, CA95817 2201, USA
    Ann Pharmacother 39:1182-7. 2005
    ..Data regarding outpatient use of any LMWH in pulmonary embolism (PE) or tinzaparin in DVT while transitioning therapy to a vitamin K antagonist are limited...
  54. ncbi request reprint Use of lepirudin in patients with heparin-induced thrombocytopenia and renal failure requiring hemodialysis
    W E Dager
    Department of Pharmaceutical Services, University of California Davis Medical Center, Sacramento, CA 95817 2201, USA
    Ann Pharmacother 35:885-90. 2001
    ..To report two cases of successful lepirudin use in two patients with heparin-induced thrombocytopenia (HIT) and renal failure...
  55. ncbi request reprint Co-morbidity is a strong predictor of early death and multi-organ system failure among patients with acute pancreatitis
    Charles Frey
    Department of Surgery, University of California Davis, Davis, CA, USA
    J Gastrointest Surg 11:733-42. 2007
    ..We conclude that advancing age and the number of chronic comorbid conditions are very strong predictors of early death among patients with acute pancreatitis...
  56. ncbi request reprint Epidemiology of venous thromboembolism in 9489 patients with malignant glioma
    Thomas J Semrad
    Department of Internal Medicine, University of California Davis School of Medicine, Sacramento, California 95817, USA
    J Neurosurg 106:601-8. 2007
    ..The authors sought to define the incidence of symptomatic venous thromboembolism (VTE) in patients harboring malignant gliomas...
  57. ncbi request reprint Do patients followed in anticoagulation clinics for antiphospholipid syndrome meet criteria for the disorder?
    Andrew S Dunn
    Division of General Medicine, Mount Sinai School of Medicine, 1470 Madison Ave, Box 1087, New York, NY 10029, USA
    Thromb Haemost 94:548-54. 2005
    ..A quality improvement program that includes review of cases referred for chronic anticoagulation care is recommended to ensure appropriate testing and treatment of patients with suspected APS...
  58. ncbi request reprint DVT prophylaxis and anticoagulation in the surgical patient
    Peter Kaboli
    Division of General Medicine, University of Iowa Hospitals and Clinics, 200 Hawkins Drive, Iowa City, IA 52242, USA
    Med Clin North Am 87:77-110, viii. 2003
    ..Finally, we review the perioperative management of patients on long-term oral anticoagulation...
  59. ncbi request reprint High risk for venous thromboembolism in diabetics with hyperosmolar state: comparison with other acute medical illnesses
    C R Keenan
    Division of General Internal Medicine, University of California, Davis, Sacramento, CA, USA
    J Thromb Haemost 5:1185-90. 2007
    ..Objectives: To determine the risk of VTE in patients hospitalized for diabetes with hyperosmolar state compared to patients with other acute medical illnesses...
  60. ncbi request reprint Validation of the Canadian clinical probability model for acute venous thrombosis
    G Patrick Shields
    University of California, Davis, USA
    Acad Emerg Med 9:561-6. 2002
    ..To validate the predictive value of the Canadian clinical probability model for acute venous thrombosis, which, to the best of the authors' knowledge, has not been done in emergency department (ED) settings outside of Canada...
  61. doi request reprint Venous ultrasound testing for suspected thrombosis: incidence of significant non-thrombotic findings
    Mark E Sutter
    Department of Emergency Medicine, University of California, Davis Medical Center, Sacramento, California 95817, USA
    J Emerg Med 36:55-9. 2009
    ..Further research is needed to determine if D-dimer plus a clinical probability tool will include or exclude the patients with clinically significant major findings...
  62. doi request reprint The incidence of venous thromboembolism and its effect on survival among patients with primary bladder cancer
    Rasanamar Sandhu
    Department of Internal Medicine, Division of Hematology Oncology, University of California Davis, Sacramento, California, USA
    Cancer 116:2596-603. 2010
    ..The incidence, risk factors, time course, and impact on survival of venous thromboembolism (VTE) in a large, population-based study of patients with bladder cancer have not been identified previously...
  63. pmc Epidemiology of cancer-related venous thromboembolism
    Ted Wun
    Division of Hematology and Oncology, Departments of Internal Medicine and Pathology, Clinical and Translational Sciences Center CTSC, University of California, Davis Cancer Center, 4501 X Street, Sacramento, CA 95187, USA
    Best Pract Res Clin Haematol 22:9-23. 2009
    ..Finally, a small percentage of patients with idiopathic VTE and no clinical or laboratory evidence of cancer may harbour an aggressive but 'occult' malignancy likely causally linked to the development of VTE...
  64. pmc Venous thromboembolism in patients with acute leukemia: incidence, risk factors, and effect on survival
    Grace H Ku
    Division of Hematology and Oncology, School of Medicine, University of California San Diego, CA, USA
    Blood 113:3911-7. 2009
    ..In the patients with ALL, development of VTE was associated with a 40% increase in the risk of dying within 1 year. The incidence of VTE in acute leukemia is appreciable, and is comparable with the incidence in many solid tumors...
  65. ncbi request reprint Protein C, antithrombin, and venous thromboembolism incidence: a prospective population-based study
    Aaron R Folsom
    Division of Epidemiology, School of Public Health, University of Minnesota, Minneapolis 55454 1015, USA
    Arterioscler Thromb Vasc Biol 22:1018-22. 2002
    ..Attributable risk estimates suggest that low protein C levels account for approximately 2.5% of venous thromboembolic events in the ARIC population...
  66. ncbi request reprint Electronic alerts to prevent venous thromboembolism
    Richard H White
    N Engl J Med 352:2349-50; author reply 2349-50. 2005
  67. ncbi request reprint Comparison of outcomes after hospitalization for deep venous thrombosis or pulmonary embolism
    Susan Murin
    Thromb Haemost 88:407-14. 2002
    ..Venous thrombosis and pulmonary embolism appear to be distinct, albeit overlapping, clinical entities with different natural histories...
  68. ncbi request reprint Seasonal dynamics of soil micronutrients in compost-amended bermudagrass turf
    Tony L Provin
    Department of Soil and Crop Sciences, Texas A and M University, 2474 TAMU, College Station, TX 77843 2474, United States
    Bioresour Technol 99:2672-9. 2008
    ..Composts only influenced the magnitude of changes in micronutrient concentrations, as similar seasonal trends occurred for both compost-amended and unamended soils...
  69. ncbi request reprint Compost impacts on dissolved organic carbon and available nitrogen and phosphorus in turfgrass soil
    Alan L Wright
    Everglades Research and Education Center, University of Florida, 3200 E Palm Beach Road, Belle Glade, FL 33430 4702, United States
    Waste Manag 28:1057-63. 2008
    ..Seasonal variability of SOC, DOC, and available P was likely related to St. Augustinegrass growth stages as well as precipitation, as declines occurred after precipitation events...